Introduction
One of the greatest surprises of high-throughput transcriptome analysis in past years is the discovery that our mammalian genome is pervasively transcribed into many different complex families of RNA.
1,2 Among these, microRNAs are now known to regulate virtually all aspects of cardiovascular biology, 3 and promise to be a useful biomarker for disease diagnosis and prognosis. 4 Another class of RNA called long non-coding RNA regulate cardiomyocyte differentiation and pathophysiology, 5, 6 fetal gene reprogramming during the myocardial stress-response, 7 and turns out occasionally to code for previously undetected micropeptides that again regulate important aspects of cardiac biology. 8 Overall,
RNA-mediated therapeutics and biomarkers are hotly pursued candidates for cardiovascular disease. 6, 9 Circular RNA (circRNA) is yet another newly validated RNA species, now attracting widespread attention. appears to take place co-transcriptionally. 18 Intronic regions flanking many circRNA are markedly longer and enriched for ALU repetitive elements. 19 The exon-exon back-splice may involve only a single exon (as in Figure 1A ), forming a single exon circRNA, or in some cases several contiguous exons in the same gene that may be linearly spliced with the most distal 5 0 and 3 0 exons back-spliced to form a multi-exonic circRNA.
It follows that alternative splicing may therefore also affect circRNA isoforms from within the same gene locus. CircRNA that spans exons from neighbouring genes has not been described. Instead, intronic circRNA and circRNA that incorporate exon-intron, also exist. 20, 21 Because of its circularity, circRNA lacks an 'open-end' rendering this RNA species resistant to exonuclease RNase-R digestion. Resistance to exonucleolytic RNA decay confers circRNA stability and likely gives circRNA a longer in vivo half-life compared with linear forms of RNA such as messenger RNA. 12 Alhasan et al. 22 found that circRNA are 17-188-fold enriched in anucleate human platelets relative to nucleated cells. Degradation resistance is therefore proposed to make circRNA ideal surrogate markers compared with linear RNA in the absence of transcription in platelets. Independent studies have confirmed the widespread expression of circRNA in different tissues, with contexts of differential expression implicating their biological relevance in some cases. 13 20 Szabo et al. 29 reported the increasing expression of circRNA from the gene NCX1 (Na þ /Ca þþ exchanger, also known as SLC8A1) during cardiomyocyte differentiation from human embryonic stem cells (hESC). The genomewide expression of circRNA in mammalian hearts has been published, 30 but a deeper analysis, also incorporating comparisons across other noncardiac tissue types is still lacking.
To systematically identify and analyse for cardiac-expressed circRNAs, we deeply sequenced ribosomal-depleted RNA-seq libraries, and filtered specifically for head-to-tail back-spliced exon-exon junction reads. For human, we extracted total RNA from 12 human hearts, which included hearts from healthy normal controls, patients with ischaemic and non-ischaemic dilated cardiomyopathy (ICM and DCM), as well as hypertrophic cardiomyopathy (HCM). We also performed the same procedure for RNA-seq libraries constructed from a differentiation protocol tracking hESC to differentiated cardiomyocytes in vitro (D0, 1, 5, 14 and 28). For mouse, we took cardiomyocytes-only isolated from the hearts of mice that had undergone pressure-overload hypertrophy following transverse-aortic constriction (TAC) compared with Shamoperated mice. For validation, we performed Reverse-transcription Polymerase Chain Reactions (RT-PCR), Sanger sequencing and quantitative RT-PCR. Single molecule RNA Fluorescence In Situ Hybridization (smRNA-FISH) was also performed for the highly abundant circRNA candidate, circSlc8a1-1.
Methods

Human and mouse hearts
Human left ventricular (LV) samples (see Supplementary material online, Table S1 ) were obtained through an IRB protocol approved by the Papworth (Cambridge) Hospital Tissue Bank Review Board and the Cambridgeshire Research Ethics Committee (UK). Written consent was obtained from all individuals according to the Papworth Tissue Bank protocol, conforming to the Declaration of Helsinki. Diseased tissues were from patients undergoing cardiac transplantation for end-stage heart failure, and harvested as previously described. 31, 32 Healthy normal LV were from healthy male individuals who had consented to research organ donation through the UK Human Tissue Bank and Ethical Tissue (The ICT Bioincubator, University of Bradford, West Yorkshire, UK). Mouse hearts were harvested for cardiomyocytes-only from TAC-and shamoperated mice, 3 weeks following surgery, as previously described. 33, 34 Echo data confirmed consistent pressure-overload hypertrophy in TACoperated mice (see Supplementary material online, Table S1 ). Animal procedures were carried out on an Institutional Approved protocol for animal use, and conformed to guidelines from Directive 2010/63/EU on the protection of animals used for scientific purposes. Isoflorane 4% mixed with oxygen, was used for inhalation anaesthesia in mice prior to cardiac harvest. Mouse CM-only were harvested according to a recently published method, yielding >95% purity. 35 Samples used for human hearts were based upon availability, whereas sample size for mouse sham/TAC was based upon the anticipated differential expression of coding and non-coding RNA as calculated in Matkovich et al. 
hESC to cardiomyocytes differentiation
The hESC line H1 was maintained using mTeSR media in Matrigel coated tissue culture plates and passaged regularly using a 50/50 mix of dispase and collagenase IV (both at 1 mg/mL). Two days prior to starting differentiation, cells were dissociated using Accutase and seeded as single cells in Matrigel-coated 12-well plates. Differentiation was performed following the published protocol by Lian et al. 37 10 mM of CHIR99021 was added on day 0 and left for 24 h followed by medium change. 5 mM IWP was added on day 3 and left for 48 h. Culture medium from day 0 to day 7 was RPMI1640 plus B-27 serum-free supplement without insulin. From day 7 and onwards, RPMI1640 with B-27 serum-free supplement (with insulin) was used and changed every 2-3 days. Coverslips were transferred onto glass slides with mounting medium (Vectashield) and imaging was performed on an upright microscope (Nikon Ni-E) with 100Â Objective (Nikon) on a cooled CCD/CMOS camera (Qi-1, Qi-2, Nikon). Controls used were no-probe control, and separately, an unrelated 2.2 kb bacterial RNA probe that does not bind to mouse sequences. To demonstrate the specificity of the LNA probe for circSlc8a1-1 cells were treated with RNase R (10U) for 30 min and then fixed again before being subjected to the above FISH protocol.
Preparation
Detection, annotation and quantification of circRNA
RNA-seq data were analysed using an efficient and unbiased de novo circRNA identification pipeline known as CIRI, 39 with default parameters.
This method detects back-spliced junction reads following the alignment result of Burrows-Wheeler Aligner (BWA-MEM), 40 and performs systematic filtering to exclude false positives. CIRI analyses all alignment records in SAM file generated by BWA-MEM, and looks for potential back-spliced junction reads which are made up of two segments which align to the reference genome in chiastic order. CIRI requires the candidate back-spliced junction reads to align in the same chromosome and strand. Unlike the other method used in previous studies, 12, 16, 18, 25, 41 CIRI takes advantage of the paired-end mapping information for preliminary filtering of false positive back-spliced junction reads by excluding those candidates with its paired reads not mapped within the region of the putative circRNA range. Next, CIRI filters candidate junction reads that are not flanked by the canonical splicing signal (GT-AG) nor supported by exon boundaries provided in GENCODE (version 19 for hg19 and M1 for mm9) GTF annotation file. We required our circRNA candidates to be supported by at least two unique back-spliced reads. High-confidence circRNA isoforms were defined as only those that satisfied the further criteria of ones being detected in at least two samples. We annotated our cardiac circRNA candidates to hg19 and mm9 GENCODE (version 19 for hg19 and M1 for mm9).
Relative expression level of circRNA isoforms is quantified in SRPBM (Spliced Reads per Billion Mapped Reads):
where x is the total number of back-spliced junction reads and n is the total number of mapped reads. We use backspliced-to-linear ratio to determine the relative expression of circRNA with respect to the cognate linear mRNA that stems from the same exon.
where c represents the total back-spliced junction read count that spans both ends of the back-spliced exon (s), l 1 and l 2 represents the total linear read count that spans left and right linear-spliced junctions of the same exon(s), respectively.
External RNA-seq datasets
rRNA-depleted RNA-seq datasets of various human tissues from ENCODE were used. The ENCODE experimental accession: ENCSR000AEW (cerebellum), ENCSR000AFE (parietal lobe), ENCSR000AFB (liver), ENCSR000AFI (stomach), ENCSR000AFF (skeletal muscle tissue), ENCLB223ZZZ (heart). External rRNA-depleted RNA-seq datasets of human pluripotent-to-cardiomyocytes differentiation were also used (NCBI accession: GSE76523). 42 
Results
Cardiac-expressed circRNAs are derived from highly expressed cardiac protein-coding and non-coding genes
We performed deep RNA-seq on ribosomal-depleted total RNA extracted from a panel of human full-thickness LV myocardial explants comprising of three control hearts, three hearts each from patients with non-ischaemic end-stage heart failure (DCM), and ischaemic end-stage heart failure (ICM), HCM. (see Supplementary material online, Table S1 , total 12 human hearts). We also undertook the same procedure for cardiomyocytes-only isolated from mouse hearts 35 pressure-overload hypertrophy following TAC (3 weeks post-TAC) and Sham-operated controls (N = 12 for Sham and N = 13 for TAC; see Supplementary material online, Table S1 ). Paired-end sequencing reads were aligned to reference genomes (hg19 for human, mm9 for mouse) using BWA. Head-to-tail back-spliced junctions were detected using an efficient and unbiased algorithm for de novo circRNA identification, CIRI. 39 CircRNA were called for each back-splice junction with a minimum coverage of at least two uniquely mapped reads, together with GT/AG splicing signals. Figure 1A shows an example of sequencing backspliced reads leading to the identification of a single-exon circRNA. Supplementary material online, Table S1 summarizes the tissue information and quality control metrics of sequencing libraries that we generated in this study. We generated an average of 112 million mapped reads per human sample. Majority of the mapped reads were non-spliced reads (85%). $11% of the total reads were linear spliced reads. Less than 1% of the total reads were back-spliced reads.
In total, we detected 15 318 and 3017 circRNA in human and mouse hearts, respectively ( Figure 1B , see Supplementary material online, Figure  S1A and Tables S2 and S3) . Among these, 6448 and 1007 were high-confidence exonic circRNA expressed in two or more human and mouse hearts, respectively. Other studies also consistently found more circRNA in human tissue than mouse 11, 14, 16, 41, 43 . Even though we had achieved a similar number of uniquely mapped reads from our mouse and human RNA-seq libraries, the number of back-spliced reads and circRNA identified in mouse were significant lower despite using the same algorithm and criteria. For human, we annotated all cardiac circRNA junctions with GENCODE v19 database. 82.32% (12 611/ 15 318) of the circRNA we identified were derived from exons and generated from individual linear cognate genes. The rest were annotated to exon-intron boundaries (1079/15 318), intron-only (2 out of 15 318: see Supplementary material online, Table S2 , validated by PCR in Supplementary material online, Figure S2A ) and others. Majority of the exonic circRNAs were spliced from coding exons (CDS) (96.42%, 12 160/12 611). Similar to human, majority of the mouse cardiac circRNA were exonic (72.35%, 2183/3017) and also mainly annotated to CDS boundaries (2069/2183) (see Supplementary material online, Figure  S1A ). Since RNaseR-treatment of RNA reliably purifies for circRNA species but requires a large quantity of starting RNA material, we compared our circRNA against RNaseR-treated RNA-seq in three DCM hearts and found good reproducibility (see Supplementary material online, Figure S1B ).
On the basis of back-spliced junctions and existing exon-exon splicing annotation, the median predicted number of exons per cardiac circRNA is four (minimum: 1, average mean: 6, max: 153). The total number of single exonic circRNA was $8% (1005/12 611), while $16% (2046/12 611) were predicted to span at least 10 exons (see Supplementary material online, Table S2 ). The longest circRNA was circTTN-366, predicted to span 153 exons (see Supplementary material online, Table 2 and Figure S1C) .
Although the majority of human exonic cardiac circRNAs (95.25%, 12 012/12 611) had an average coverage of less than 10 back-spliced junction reads, 35 highly expressed circRNAs had a high-average read count of more than 50, making them the most highly expressed circRNA in human hearts (Table 1, Figure 1D ). These included circSLC8A1-1, circTPM1-1, circTTN-90, circTTN-275, circHIPK3-2, circEXOC6B-14, circALPK2-2, circMB-2, circNEBL-19, circMYBPC3-3 and circRYR2-113. Non-protein-coding genes also generated a high-number of circRNA ( Figure 1D) . Among the top expressing circRNA from corresponding annotated non-coding linear genes were circTTN-AS1-1, circFLG-AS1-1, circMKLN1-AS1-1, and circMEF2C-AS1-1. Consistently, for protein-coding genes, but seemingly not for non-coding genes, we noted that linear genes with the highest expression produced proportionally the highest abundance of circRNA ( Figure 1D ). 30 of the top 100 most highly expressed linear cardiac genes produced at least one circRNA isoform each, including MYL2, TPM1, DES, MB, MYH7, TTN, FHL2, and TNNT2 ( Table 2) . On the other hand, top cardiac-expressed linear genes that did not produce any circRNA included ACTC1, MYL12A, NPPA, and TCAP. Expression abundance of circRNA-producing linear genes was significantly higher than linear genes that did not produce detectable circRNA (average FPKM of circRNA-producing linear genes: 120.98; average FPKM of other genes: 12.20 ; Wilcoxon rank sum test with continuity correction P-value <2:2 Â 10 À16 ). Linear genes that were not expressed in the heart did not generally show any expression of corresponding circRNA ( Figure 1D) . Remarkable exceptions to this were RBL1, PIK3R2 and RP1-27O5. 3 . These were non-cardiac-expressed linear protein-coding genes that generated circRNA in the heart, at least in our analysis. The most abundant human cardiac-expressed circRNA by far was a single-exon circular isoform from the Na þ /Ca þþ exchanger gene SLC8A1, also known as NCX1, with an average of 2030 back-spliced junction reads across all human heart samples (Table 1, Figure 1D) . In mouse cardiomyocytes, the same exon in Slc8a1 also generated the 2nd most abundant mouse cardiomyocyte circRNA (circSlc8a1-1, Table 3 .
For all genes, linear junctions largely outnumbered corresponding backspliced junctions (e.g. circTPM1-1 and circTNNT2-12 in Figure 1E ), but in some prominent cases, such as circSLC8A1-1, the back-spliced junction was up to 40 times more abundant than the corresponding linear junction, suggesting that the circSLC8A1-1 is more abundant than linear SLC8A1 transcripts, at least based on assessment at this spliced junction ( Figure 1E) . We further determined that this spectrum of backsplice-tolinear ratio is consistent and reproducible across different hearts (average spearman correlation rank, r =0.85, P-value <0.001) (see Supplementary material online, Figure S1D ).
The longest human linear mRNA TTN has the largest number of circRNA isoforms
On average, each circRNA-producing linear gene generated three circRNA isoforms (see Supplementary material online, Table S4) . Two important cardiac genes produced more than 100 circRNA isoforms each: TTN (401 exonic circRNA isoforms, Figure 1C ) and RYR2 (177 circRNA isoforms) ( Figure 1F , Table 4 ). The same was found in mouse cardiomyocytes ( Table 5 , see Supplementary material online, Table S4 ). Non-sense or frameshift mutations in the TTN A-band domain leading to TTN protein truncations were recently implicated as a major cause for DCM. 44 , 45 We found 32 circRNA isoforms generated from within the A-band domain of TTN, but interestingly, a large diverse variety of multi-exon circRNA were generated from the I-band, which is the domain of TTN known to be most heavily linear spliced ( Figure 1C) . In general, longer linear genes correlated with more circRNA isoforms, although again, exceptions were DES and LAMA2 which are shorter genes (6 kb and 20 kb, respectively) that generated 18 and 47 circRNA isoforms each ( Figure 1F ).
Features in introns flanking cardiac-expressed circRNA
Others had observed that flanking intron lengths correlated with the production of circRNA. 12, 17 In our shortlist of cardiac-expressed circRNA, we confirmed that the average length of circRNA-flanking introns was significantly longer than genome-wide average intron length (median circRNA-flanking intron length: 7451; genome-wide average intron length: 1567; non-parametric resampling P-value <0.01; Figure 1G) . Similarly, we observed that flanking introns were significantly enriched with Alu repeats elements (percentage enrichment for introns flanking circRNA: 88%; global percentage enrichment of Alu elements in intron: 49%; non-parametric resampling bootstrap P-value <0.01; Figure 1H ). Flanking introns of the most abundantly expressed circRNA, circSLC8A1-1, are unusually long (250 618 nt) and are enriched with Alu elements. Again as exception, we noted that some highly expressed cardiac circRNAs have neither long flanking intronic lengths nor Alu element enrichment. One such example is circTPM1-1, whose left intron length is 942 nt, right intron length is 1419 nt, and is without any Alu element in either flanking intron.
Validation of cardiac-expressed circRNA candidates
To validate our shortlist of cardiac-expressed circRNA, we randomly selected 30 human and 20 mouse candidates from a range of high, moderate and low-expression levels as determined by our RNA-seq junction read-count analysis. From these, we definitively confirmed the back-spliced structure of 24/30 and 19/20 of human and mouse cardiac circRNA candidates by RT-PCR using junction-specific divergent primers and Sanger sequencing (Figures 2A-C , see Supplementary material online, Figure S2B and C). We also performed PCR on the respective genomic DNA using the corresponding divergent primers, and confirmed that back-spliced junctions were in RNA transcripts and not due to genomic exon reshuffling or tandem duplications. By performing the same RT-PCR on RNase-R treated RNA samples, we further confirmed that back-spliced products were present in RNA circles. We also compared linear and backspliced PCR products by using convergent and divergent primers, respectively, and RT by using oligo-dT or random hexamers, and further confirmed the circularity of candidates (see Supplementary material online, Figure S2D ). Using single molecule RNA-FISH, we established the cytoplasmic localization of circSlc8a1-1 in adult mouse cardiomyocytes ( Figure 2D and see Supplementary material online, Figure S2E ). 
3.5
Heart-specificity of cardiac-expressed circRNA candidates and lack of differential expression of circRNA in human diseased hearts
Next we downloaded tissue RNA-seq datasets from the ENCODE Project Consortium and analysed with the same algorithm for unbiased comparison against our cardiac circRNA shortlist. We identified 1664 cardiac-specific circRNA which were detected in hearts only (see Supplementary material online, Figure S2A ). Gene ontology confirmed that these heart-specific circRNAs are highly enriched for cardiac-specific biological processes (adjusted P-value <1 Â 10 À5 ) including cytoskeleton organization, actin-mediated cell contraction, muscle filament sliding, cardiac muscle contraction and myofibril assembly (see Supplementary mate rial online, Table S5 ), and they corresponded largely genes that are similarly cardiac-specific (see Supplementary material online, Figure S2A) . Conversely, other cardiac-expressed circRNA are commonly expressed in other organs. This included the most abundant cardiac circSLC8A1-1, which was also highly expressed in skeletal muscle, liver, stomach, temporal lobe and cerebellum (see Supplementary material online, Figure S2A ). Next we asked whether cardiac circRNA were differentially expressed between healthy and diseased hearts. Analysis based on junction count from our dataset did not yield any differentially expressed candidates with strong statistical significance. Similarly using the panel of primers that we employed for validating the 24 candidates above, we found that circRNA expression was largely stable across all our human heart samples (see Supplementary material online, Figure S2B) . Similarly, in Sham-and TAC-operated mouse hearts, we also did not detect any significant circRNA differential expression (see Supplementary material online, Figure S2C ), despite characteristic changes of stress-response linear genes such as Nppa, Nppb, and Myh7.
CircRNA expression in the time-course of cardiomyocyte differentiation
In addition to assessing normal and diseased heart tissue, we also turned our attention to circRNA in the differentiation time-course of hESC to hESC-cardiomyocytes. In this dataset, we found a total of 6853 exonic circRNAs across all five time-points (see Supplementary material online, Table S6 ). We made a comparison between circRNA expressed in the time-course and adult human cardiac-expressed circRNA curated from above, and found an increasing overlap with cardiac-expressed circRNA, and decreasing overlap with D0 hESC-expressed circRNA across the progressive time-points ( Figure 3A) . CircRNA expressed in hESCcardiomyocytes furthest along in the differentiation protocol (on D28, Figure 3B ) were originating from host genes that were statistically enriched for contractile fiber cellular components such as contractile 
fiber (26 genes, adjusted P-value = 2 Â 10 À4 ), and myofibril (26 genes, adjusted P-value = 3 Â 10 À4 ) (see Supplementary material online, Table   S7 ). 479 circRNAs had strong positive correlation with the differentiation time-course (r > 0.75, P-value <2:2 Â 10 À22 ; top candidates shown in Figure 3B ). These circRNA mapped to genes significantly enriched in GO terms such as heart development (21 genes, adjusted P-value = 5:9 Â 10 À3 Þ and anatomical structural development (55 genes, adjusted P-value = 8:4 Â 10 À3 ). Examples of circRNA with increasing abundance over the time-course were: circSLC8A1-1, circTTN-275 and circALPK2-1, which we validated by quantitative RT-PCR ( Figure 3C) .
Reflecting the significant abundance of these circRNA, each was covered by >100 back-spliced junction-reads on D28. On the other hand, 181 circRNAs showed strong negative correlation with the differentiation time-course (r < 0.75, P-value < 2:2 Â 10 À22 ; top candidates shown in Figure 3B ). These circRNAs are significantly enriched in cellular metabolic processes (101 genes, adjusted P-value = 5 Â 10 À4 ), and included circDNMT3B-4, circOSBPL10 and circFGD4-7 ( Figure 3C) . We further validated this set of time-course dependent circRNA changes in an independent analysis using a previously published RNAseq of hESC and hESC-cardiomyocytes 42 (see Supplementary material online, Figure S3 ).
Coherent with acquiring circRNA that are cardiac-specific, we also found an increase in TTN circRNA isoforms in the progressive differentiation from hESC to hESC-cardiomyocytes ( Figure 3D ). At D0, there were no circRNA expressed from the TTN loci. The number of circTTN increased along the differentiation time course. At D28, the majority of the circRNA were derived from the I-band (26/30), similar to the observation in adult human hearts.
Discussion
Just as thousands of non-coding RNA turned out to be transcribed from what was thought to be ancestral sequences or 'junk DNA' across the human genome, 46 'scrambled exons' first reported in 1991 47 are now recognized as bona-fide back-spliced junctions of abundant and widely expressed circRNA. Datasets of cardiac circRNA expression were recently published. 48, 49 Our work now extends the genome-wide analysis to deeper detail. We describe the full spectrum of cardiac circRNA expression corresponding to their cognate cardiac-expressed linear protein coding and non-coding genes. 36 of the top 100 cardiac-expressed linear genes express at least one isoform of circRNA. Generally, the most highly expressed linear genes also have the highest expression abundance of corresponding circRNA, consistent with a biogenesis mechanism that incorporates both linear and circRNA isoforms concurrently from the same gene locus. However, circRNA can also originate very rarely from the loci of non-cardiac-expressed linear genes such as RBL1 and PIK3R2, suggesting the possibility of a unique circRNA biogenesis mechanism that remains to be proven. Similarly, there are some circRNA whose abundance appears to significantly exceed their corresponding linear RNA (e.g. circSLC8A1-1), again suggesting the possibility of a disconnect between linear and circRNA biogenesis, or a prolonged stability of the circRNA compared with its linear RNA gene product. Conversely, there are also highly expressed linear cardiac genes such as ACTC1 and NPPA that do not appear to generate any circRNA.
circSLC8A1 and circTTN isoforms
Regardless of their mechanism of biogenesis or how their expression abundance might be regulated, our study reports a few key discoveries for cardiac circRNA. The most abundant circRNA in human hearts is a single-exon isoform generated from exon 2 of the Na þ /Ca þþ exchanger gene, SLC8A1 (or NCX1). Arising from the same exon in mouse, circSlc8a1-1 is also abundantly expressed in mouse cardiomyocytes. In fact Li and Lytton 50 made the prescient discovery of this circRNA before and showed evidence that this circRNA may encode a 602-amino acid truncated NCX1 protein. Translation of circular transcripts has been reported previously 50 and may reflect a potential physiological function for circSLC8A1-1. However, in general, only linear but not circular forms of RNA are present in heavy polyribosome cell fractions, 41 implying that circRNA are not usually translated. Our finding of the near-exclusive cytoplasmic localization of circSLC8A1-1 in the cardiomyocyte nonetheless suggests that its role is likely to be extra-nuclear. Indeed all circRNA are predominantly cytoplasmic localized. 12 The role of circSLC8A1-1 will need further assessment by knockdown that targets the circRNA but not its linear transcript. Another observation from our study is that the longest human transcript TTN also has the largest number of circRNA isoforms (402 in total) in the heart, followed by 177 circRNA isoforms encoded by another long cardiac gene RYR2. By far the majority of TTN circRNA arise from the TTN locus encoding the protein I-band domain, upstream of the Aband domain, which is in turn the major site of disease-causing non-sense and frameshift mutations. 44, 45 Among its domains, the TTN I-band is known to be the most heavily spliced, so it remains possible that the multi-exonic large spectrum of circRNA isoforms in the I-band are mechanistically linked to the abundance of linear splicing in this domain. It would be of interest to know if the expression of TTN I-band domain circRNA isoforms is significantly perturbed in patients with diseasecausing TTN mutations, and if so, whether this influences disease onset or progression. Cardiac biopsies from patients with DCM will be needed to investigate these possibilities. None of our patient samples harboured TTN non-sense or frameshift mutations. The production of DMD RNA circularization in the presence of a DMD frameshift mutation has been associated with a more severe phenotype for muscular dystrophy. 51 We also detected 43 DMD circRNA isoforms in our samples of human hearts. Expression levels of the full spectrum of DMD circRNA isoforms will also merit further investigation in patients with Duchenne or Beckers muscular dystrophy.
Differential expression of circRNA in healthy and diseased hearts, and in cardiomyocyte differentiation
From back-spliced junction analysis of our human hearts, we did not find any statistically significant circRNA that were differentially expressed in disease. Indeed even with our sham-and TAC-operated mouse hearts, we did not find any significant differential circRNA expression. Differential expression was instead significant in the progression of cardiomyocyte differentiation. All together, this is reminiscent of the finding reported by Matkovich et al. 36 where lncRNA were regulated as a major factor during the developmental transition between late embryonic and adult hearts, but not for the maladaptive compensation that distinguishes normal from pathological diseased hearts in the adult. Interestingly, Du et al. 52 found that a candidate circRNA, circFoxo3, was highly expressed in hearts of aged patients and mice. Moreover, silencing circFoxo3 inhibited senescence of mouse embryonic fibroblasts, whereas ectopic expression of circFoxo3 induced senescence. Our own findings of the lack of differential expression between age-matched healthy and diseased hearts will need further study for replication. The lack of circRNA differential expression in disease progression may be a reflection of their Genome-wide cardiac circRNA expression long half-life and stability compared with linear transcripts. Eunuka et al. 53 reported that circRNA in EGF-stimulated cells were stably expressed whereas mRNA and miRNA changed within minutes; and proposed the explanation to be the long half-lives of circRNA.
Conversely, an important limitation we may have faced is the lack of sequencing depth for detecting circRNA differential expression given our limitation with back-spliced junction reads. On the basis of our dataset, however, it would now be possible to design targeted back-splice array panels to assess circRNA expression in closer detail, or RNaseR RNA-seq if the starting quantity of RNA is not limiting. In contrast, at a similar sequencing depth, there was significant differential expression of circRNA in the hESC differentiation time-course. The range of circRNA differential expression may therefore be wider in cardiomyocyte differentiation than in health and disease comparisons. Even if cardiac circRNA are stably expressed and not differentially expressed in disease, a cell-type signature of circRNA expression coupled to its exonucleolytic-resistance and enhanced stability still mean that if carefully selected, circRNA may be attractive candidates for cell-identity biomarkers. Wang et al. 54 showed that the circRNA100783 is a novel biomarker for tracking immune cell ageing or immunosenescence. Indeed circRNA are also found enriched in circulating exosomes. 10 Hence, circRNA that are not differentially expressed but cardiomyocyte-specific could still be robust circulating biomarkers of disease that reflect cardiomyocyte death or myocardial damage, just as Troponin peptides are good biomarkers even though they are not differentially expressed in the myocardium during myocardial infarction. Our analysis has identified 1664 cardiac-expressed circRNA that are heart specific.
circRNA may serve important biological functions in the cardiovascular system
In another cardiovascular relevant context, a circRNA of the long noncoding RNA ANRIL at the chromosome 9p21.3 locus correlates with atherosclerosis risk alleles and expression of the nearby coding gene INK4/ARF. 55 Splice prediction algorithms identified polymorphisms in the risk interval that may regulate ANRIL splicing and circANRIL production, 55 but it remains to be shown how these alternative RNA isoforms directly contribute to disease. Boeckel et al. 25 identified a set of hypoxia-induced circRNA expressed in human umbilical venous endothelial cells. Silencing of cZNF292 reduced tube formation and spheroid sprouting in vitro, implicating a pro-angiogenic role for cZNF292. 25 A circRNA (HRCR) acts as a miR-223 sponge to inhibit cardiac hypertrophy and heart failure. 56 Hundreds of circRNA are regulated during human epithelial mesenchymal transition (EMT) and the increase in circRNA formation during EMT seems to be regulated by the RNA binding protein QKI. 57 We also found expression of circQKI in human hearts.
In summary, much work lies ahead to elucidate mechanisms of action and detailed functional relevance for the different cardiac-expressed circRNA isoforms that we have now catalogued. Our dataset forms an important human heart resource that gives the first detailed overview to the expression landscape of this emerging class of RNA and lays the foundation for future new discoveries into their role in human cardiovascular biology.
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